CS Medica AS (STU:8G8) Long-Term Debt : €1.16 Mil (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is CS Medica AS Long-Term Debt?

CS Medica AS's Long-Term Debt for the quarter that ended in Sep. 2024 was €1.16 Mil.

CS Medica AS's quarterly Long-Term Debt increased from Mar. 2024 (€1.22 Mil) to Jun. 2024 (€1.22 Mil) but then declined from Jun. 2024 (€1.22 Mil) to Sep. 2024 (€1.16 Mil).

CS Medica AS's annual Long-Term Debt increased from Sep. 2022 (€0.08 Mil) to Sep. 2023 (€1.15 Mil) and increased from Sep. 2023 (€1.15 Mil) to Sep. 2024 (€1.16 Mil).

CS Medica AS Long-Term Debt Historical Data

The historical data trend for CS Medica AS's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CS Medica AS Long-Term Debt Chart

CS Medica AS Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Long-Term Debt

Get a 7-Day Free Trial

0.41

0.18

0.08

1.15

1.16

CS Medica AS Quarterly Data
	Sep19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Long-Term Debt	Get a 7-Day Free Trial														1.15	1.21	1.22	1.22	1.16

CS Medica AS (STU:8G8) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

CS Medica AS Long-Term Debt Related Terms

Thank you for viewing the detailed overview of CS Medica AS's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

CS Medica AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CS Medica AS (STU:8G8) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Indiakaj 10, Copenhagen, DNK, 2100

Website

https://www.cs-medica.com

CS Medica AS is engaged in developing, manufacturing, and commercializing over-the-counter medical device products containing cannabinoids currently focusing on cannabidiol for the treatment of psoriasis and arthritis. It operates in two business segments such as GalaxaPharma A/S responsible for distribution operation for marketing and sales direct-to-consumer, to retailers, and e-tail and CANNORDIC A/S is engaged in research and development, establishing of global business contracts, supply of CBD ingredients and production of finished products.

CS Medica AS Headlines

No Headlines